Urologists face major cut in AWP of cancer drugs

15% cut in average wholesale price would cost urologists $142 millionin 2004, AUA says

Related Content:

Drug Therapy

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria

FDA approves androgen inhibitor for metastatic PCa